Our integrated platform is meticulously designed to overcome the inherent challenges of therapeutic targeting, ensuring that your valuable cargo reaches its intended destination with exceptional specificity and efficacy. We leverage a synergistic approach, combining advanced delivery systems/drugs with sophisticated targeting modules, to unlock new possibilities in medicine.
Advanced lipid nanoparticle (LNP) formulation and optimization for precise delivery to specific organs and tissues.
Comprehensive solutions for enhancing the bioavailability and targeted delivery of small molecule therapeutics.
Robust analytical and biological assays to thoroughly characterize delivery systems and assess their efficacy and safety.
Expert design and execution of in vivo studies to evaluate drug distribution, metabolism, and therapeutic effects.
Our specialized platform for the precise chemical conjugates and functionalization of delivery systems with targeting modules.
Guidance and support through the critical stages of Investigational New Drug (IND) application, including Good Manufacturing Practice (GMP) compliant manufacturing strategies.
Click the Video to Learn More about Liposomal Delivery Systems in Cancer Therapy
Creative Biolabs offers comprehensive delivery solutions tailored for a wide spectrum of drugs, ensuring optimal performance regardless.
Small molecule
Enzyme
Protein Peptide
DNA
mRNA
siRNA
MicroRNA
ASO
Virus
CRISPR-Cas9
Probe
Plasmid
Our modular approach integrates a diverse array of advanced delivery systems, including liposomes, exosomes, LNPs, and more. Each system is carefully designed and optimized to ensure efficient drug loading, protection, and release.
Versatile lipid-based vesicles offering excellent biocompatibility and capacity for encapsulating both hydrophilic and hydrophobic drugs.
Advanced lipid-based delivery systems, particularly effective for nucleic acids like mRNA, providing stability and efficient cellular uptake.
Naturally occurring nanovesicles with inherent targeting capabilities and low immunogenicity, ideal for biological cargo and cell-to-cell communication.
Non-replicating, self-assembling protein structures that mimic viruses, offering robust delivery potential for various payloads.
Self-assembling systems formed by amphiphilic molecules, suitable for hydrophobic drug encapsulation and improved systemic circulation.
Three-dimensional polymeric networks capable of absorbing large amounts of water, offering controlled release and localized delivery.
Creative Biolabs excels in the precise conjugate of therapeutic agents with our sophisticated targeting modules and delivery systems. Our advanced conjugation platform enables the creation of highly specific and potent drug conjugates, designed to maximize therapeutic efficacy while minimizing off-target effects. We offer expertise across a range of conjugation strategies.
At Creative Biolabs, our distinction lies in our integrated, customizable, and highly advanced platform.
Unparalleled flexibility and precision through combining diverse delivery systems and targeting modules.
Rigorous in vitro and in vivo analysis ensures safety, efficacy, and stability.
Tailored solutions and a collaborative approach for specific project needs.
End-to-end guidance from concept to IND-enabling studies and GMP manufacturing, streamlining development.
Continuous integration of the latest advancements in drug delivery technology.
Dedicated to addressing complex targeting and bioavailability challenges.
Our mature LNP platform offers efficient targeting solutions for various organs and tissues, including the brain, heart, lung, liver, spleen, muscle, and T cells. We also provide customized targeting system development services to meet specific research and clinical needs.
Fig. 1 In vivo expression and distribution of Creative Biolabs' lung-targeted mRNA-LNP in mice.
Our lung-targeted LNPs show exceptional efficiency in delivering mRNA to the lungs, offering great potential for treating respiratory diseases and conditions.
Targeted drug delivery minimizes off-target effects, reduces systemic toxicity, and increases therapeutic efficacy by concentrating the drug at the site of disease.
We use robust design, advanced bioconjugation, and extensive in vitro and in vivo testing to confirm our targeting delivery systems precisely bind to intended sites with minimal off-target effects.
Yes, we support projects from initial concept through IND-enabling studies, helping identify delivery systems, targeting modules, and providing early proof-of-concept data.
Yes, our platform handles a wide range of drugs, from small molecules to complex biologics and novel nucleic acids (mRNA, siRNA, miRNA, ASO, plasmid DNA), adapting strategies for optimal delivery.
We offer extensive customization for delivery systems, targeting modules, conjugation strategies, and assay development, ensuring solutions are precisely aligned with your unique project needs.
Partner with Creative Biolabs to unlock the full potential of your therapeutics through precise and effective targeted drug delivery.
Customer Review
Creatibe Biolabs' custom LNP was the only solution that successfully delivered our CRISPR-Cas9 payload across the blood-brain barrier with high efficiency and low toxicity.”
Dr. Evelyn Reed
Postdoctoral Researcher, Leading University
Our siRNA candidate was failing due to off-target toxicity, but Creatibe Biolabs' team rapidly redesigned our LNP using their modular platform, rescuing our preclinical program.”
Ben Carter
Project Manager
Achieving cytosolic delivery of our protein degrader with Creatibe Biolabs' exosome platform was the key to unlocking our candidate's full therapeutic potential.”
Dr. Kenji Tanaka
Principal Scientist, Large Pharma Corp
Our oncology drug's efficacy was limited by poor tumor accumulation. Creatibe Biolabs' peptide-conjugated liposomes provided the precise targeting we needed, dramatically increasing the drug's therapeutic index.”
Dr. Clara Schmidt
Senior Scientist, Oncology Innovations Inc.
We required a delivery system that would only release its payload in the tumor's acidic microenvironment. Creatibe Biolabs' pH-responsive liposomes performed flawlessly, minimizing systemic exposure.”
David Chen
Formulation Scientist
Outstanding expertise in antibody engineering.The team's attention to detail and innovative approaches have sianificantly accelerated our development timeline.
Sarah L.
Senior Research Scientist
.png)
Antibody-Drug Conjugates 
Lipid–Drug Conjugate .png)
Antibody Fragment-Drug conjugates .png)
Small Molecule-Drug Conjugates .png)
Peptide-Drug Conjugates .png)
Virus-Like Drug Conjugates .png)
Immune-stimulating Antibody Conjugate .png)
Degrader-Antibody Conjugates .png)
Antibody-Oligonucleotide Conjugates .png)
Aptamer-Drug Conjugates .png)
Radionuclide Drug Conjugates